1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone>98.0%(GC)500g

Porta imbuto, per 2 coni di sedimentazione, 1 Pezzo

Methyl 3-chloro-5-iodobenzoate, 98.0%, 10g

6-Bromo-5-methoxypyridin-3-amine, 95.0%, 5g

5-Bromopyridine-2,3-dicarboxylic acid, 95.0%, 100g

Aldeide laurica, min 98%, per sintesi, 50 ml, confezione in vetro

2,5-Dibromo-3-nitrotoluene, 1g

Capillare per punto di fusione, 75 mm, 1.55 mm, 1.15 mm, 1000 Pezzo(i)

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoate, 97.0%, 5g

4-Bromothiophenol, 98.0%, 100g

Ethyl 3-methyl-4-nitrobenzoate, 95.0%, 25g

N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide, 98%, 25mg

2-cyano-n-(3-methoxybenzyl)acetamide, 1g